Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Slaughter

Showing results (301-310 of 338) with videos related to

Pageof 34
Sort By:
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist DeviceClaudius Mahr, Edwin McGee, Anson Cheung, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 16, 2003
In vivo evaluation of the biocompatibility of the totally implantable ventricular assist device (HeartSaver VAD)Tofy Mussivand, Hiroaki Harasaki, Kenneth Litwak, et al.
The New England Journal of Medicine|November 19, 2009
Advanced heart failure treated with continuous-flow left ventricular assist deviceMark S Slaughter, Joseph G Rogers, Carmelo A Milano, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 15, 2014
An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trialSamer S Najjar, Mark S Slaughter, Francis D Pagani, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 26, 2014
Feasibility study of particulate extracellular matrix (P-ECM) and left ventricular assist device (HVAD) therapy in chronic ischemic heart failure bovine modelKevin G Soucy, Erin F Smith, Gretel Monreal, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 25, 2014
Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort studyKeyvan Karkouti, Hilary P Grocott, Richard Hall, et al.
JACC. Heart Failure|July 16, 2018
HVAD: The ENDURANCE Supplemental TrialCarmelo A Milano, Joseph G Rogers, Antone J Tatooles, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 15, 2019
Comparison of Neurologic Event Rates Among HeartMate II, HeartMate 3, and HVADSong Li, Jennifer A Beckman, Richard Cheng, et al.
Circulation|May 8, 2013
Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart AssociationJohn S Rumsfeld, Karen P Alexander, David C Goff, et al.
Circulation|January 15, 2013
Prospective, multicenter study of ventricular assist device infectionsRachel J Gordon, Alan D Weinberg, Francis D Pagani, et al.
Pageof 34

Showing results (301-310 of 338) with videos related to

Sort By:
Pageof 34
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 3, 2020
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist DeviceClaudius Mahr, Edwin McGee, Anson Cheung, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 16, 2003
In vivo evaluation of the biocompatibility of the totally implantable ventricular assist device (HeartSaver VAD)Tofy Mussivand, Hiroaki Harasaki, Kenneth Litwak, et al.
The New England Journal of Medicine|November 19, 2009
Advanced heart failure treated with continuous-flow left ventricular assist deviceMark S Slaughter, Joseph G Rogers, Carmelo A Milano, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 15, 2014
An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trialSamer S Najjar, Mark S Slaughter, Francis D Pagani, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 26, 2014
Feasibility study of particulate extracellular matrix (P-ECM) and left ventricular assist device (HVAD) therapy in chronic ischemic heart failure bovine modelKevin G Soucy, Erin F Smith, Gretel Monreal, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 25, 2014
Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort studyKeyvan Karkouti, Hilary P Grocott, Richard Hall, et al.
JACC. Heart Failure|July 16, 2018
HVAD: The ENDURANCE Supplemental TrialCarmelo A Milano, Joseph G Rogers, Antone J Tatooles, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 15, 2019
Comparison of Neurologic Event Rates Among HeartMate II, HeartMate 3, and HVADSong Li, Jennifer A Beckman, Richard Cheng, et al.
Circulation|May 8, 2013
Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart AssociationJohn S Rumsfeld, Karen P Alexander, David C Goff, et al.
Circulation|January 15, 2013
Prospective, multicenter study of ventricular assist device infectionsRachel J Gordon, Alan D Weinberg, Francis D Pagani, et al.
Pageof 34